ProfileGDS4459 / ENSG00000161896
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 24% 15% 69% 25% 26% 14% 49% 29% 39% 31% 23% 43% 33% 58% 27% 35% 25% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.5224
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.1915
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.3169
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.6825
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.4126
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.8814
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.449
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.529
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9239
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.6431
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.3223
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.0843
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.7233
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.6858
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.3727
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.9335
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.5625